Arcturus Therapeutics Holdings, Inc. (ARCT)
7.47
-0.36
(-4.60%)
USD |
NASDAQ |
May 15, 16:00
7.43
-0.04
(-0.54%)
Pre-Market: 20:00
Arcturus Therapeutics Holdings EPS Diluted (Quarterly) : -0.9487 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Twist Bioscience Corp. | -0.7134 |
| Denali Therapeutics, Inc. | -0.6882 |
| Agenus, Inc. | 1.023 |
| Curis, Inc. | -1.250 |
| LadRx Corp. | -1.453 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -26.96M |
| Revenue (Quarterly) | 0.61M |
| Total Expenses (Quarterly) | 27.57M |
| Enterprise Value | 24.93M |
| Gross Profit Margin (Quarterly) | -7.87% |
| Profit Margin (Quarterly) | -4.42K% |
| Earnings Yield | -37.70% |
| Normalized Earnings Yield | -33.97 |